Delivery Order SPE2DB22D2206-SPE2DB25FFC33

Award Date 1/14/25
Potential Completion Date 1/15/25
Potential Value $1.2K
Ultimate Awardee
Not listed
Federal Contract Vehicle
Set-Aside Type
No Set-Aside Used
Extent Competed
Full and Open Competition
Major Defense Program
Not listed
Pricing Type
Firm Fixed Price
Place of Performance
Conshohocken, PA 19428, USA
Solicitation Procedures
Negotiated Proposal / Quote
Number Of Offers Received
Not listed
Legislative Mandate
Not listed
National Interest Action
Not listed
Research Type
Not listed
Primary Consortia Member
Not listed
Similar Awards
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a pharmaceutical distributor and healthcare solutions provider. The contract is a delivery order with a firm fixed price, valued at $2,058.80, for the supply of Telmisartan-HCTZ 80-25 mg tablets. The award does not have a set-aside designation, indicating open competition. The contract is part of a larger Indefinite Delivery Contract (IDC) between Amerisourcebergen Drug Corp and the DLA Troop...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $5,984.40, is a Delivery Order with a Firm Fixed Price pricing type. It covers the procurement of Telmisartan-HCTZ 80-25 mg tablets, a cardiovascular medication, with an ultimate completion date of December 23, 2024. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC)...
This federal contract award was made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider, to deliver Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The $1,185.77 firm fixed-price delivery order is part of a larger Indefinite Delivery Contract (IDC) valued at $999,999,999 held by AmerisourceBergen with the DLA Troop Support Medical, which serves as the primary vehicle for providing a comprehensive range...
This federal contract award was issued by the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor, for the delivery of Telmisartan-HCTZ 80-25 mg tablets. The $4,144.42 firm fixed-price delivery order has a completion date of November 29, 2024 and is not designated as a set-aside. Amerisourcebergen holds a significant $999,999,999 Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, which serves as a primary vehicle for providing a...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract is for the delivery of Telmisartan-HCTZ 80-25 mg tablets, a cardiovascular medication, with an ultimate completion date of February 6, 2025 and a ceiling value of $2,644.21. The contract is a Delivery Order under a larger Indefinite Delivery Contract (IDC) with the DLA Troop Support Medical, valued at...
This federal contract award was issued by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The $9,898.67 firm fixed-price delivery order is for the supply of Telmisartan-HCTZ 40-12.5 mg tablets in 30-count units. The award is part of a larger $999,999,999 Indefinite Delivery Contract (IDC) held by AmerisourceBergen with the DLA Troop Support Medical, which provides a comprehensive range of pharmaceutical...
This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $1,910.40, is for the delivery of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count units. The contract has an ultimate completion date of January 15, 2025 and is a Firm Fixed Price Delivery Order. This award is not designated as a set-aside contract. AmerisourceBergen holds a significant Indefinite...
This is a federal contract award from the Defense Logistics Agency (DLA) to Amerisourcebergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The contract, valued at $7,455.27, is a Firm Fixed Price Delivery Order for the supply of Telmisartan-HCTZ 80-25 mg Tablets in units of 30. The contract has an Ultimate Completion Date of December 27, 2024. This award is not associated with a set-aside designation, indicating open competition. Amerisourcebergen also holds a...
This federal contract award is a delivery order valued at $3,891.44 issued to Amerisourcebergen Drug Corp by the Defense Logistics Agency (DLA) Troop Support Medical. The contract is for the supply of Telmisartan-HCTZ 80-12.5 mg tablets in 30-count blister packs. This order is part of a larger Indefinite Delivery Contract (IDC) valued at up to $999,999,999 between Amerisourcebergen and the DLA Troop Support Medical for providing a comprehensive range of pharmaceutical and medical supplies to...
This is a federal contract award made by the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award, valued at $6,840.95, is for the delivery of Telmisartan-HCTZ 80-25 mg tablets in units of 30. The contract has an ultimate completion date of January 31, 2025 and is a firm fixed-price delivery order. This contract award is not designated as a set-aside. AmerisourceBergen Drug Corp holds a significant...
  • SPE2DB22D2206
    Indefinite Delivery Contract
  • SPE2DB22D2206-SPE2DB25FFC33
    Delivery Order

This is a federal contract award from the Defense Logistics Agency (DLA) to AmerisourceBergen Drug Corp, a major pharmaceutical distributor and healthcare solutions provider. The award has a ceiling value of $1,151.76 and is a Delivery Order contract for the provision of Telmisartan-HCTZ 80-12.5 mg tablets. The contract does not have a set-aside designation, indicating open competition.

The award is associated with a larger Indefinite Delivery Contract (IDC) that AmerisourceBergen holds with the DLA Troop Support Medical, valued at $999,999,999 and running through November 2026. This IDC serves as a primary vehicle for providing a comprehensive range of pharmaceutical products and medical supplies to support military healthcare programs globally. The contract encompasses critical medical commodities including specialty medications, brand-name and generic drugs, vaccines, syringes, vials, and test kits across multiple therapeutic domains.

Generated 4/16/25, 6:05 PM